Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Low Doses of Arginine Vasopressin in Early Septic Shock Stage
NCT02053675Completed
- Sponsor
- Federal University of São Paulo
- Start
- May 2008
- Primary completion
- Apr 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of vasopressin in septic shock, sponsored by Federal University of São Paulo. Primary endpoint: Microcirculation parameters (MFI, TVD, PPV, PVD, HI) at 1 hour. Started May 2008; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02053675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053675.